Back to search

Norway· NO-ID_7DC5881E-CBB7-4C6D-B615-645D53E31413

Streptomycin x-gen

A streptomycin product containing streptomycin, registered in Norway by Pharma-Tek. The same ATC class is registered in 7 of our 19 countries.

ATC J01GA01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedStreptomycin x-genATCJ01GA01REGISTER NO.NO-ID_7DC5881E-CBB7-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Streptomycin is registered in 7 of 19 countries.

Countries holding a registration under ATC J01GA01 (streptomycin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 5 of them publish a price we can compare per daily dose

Streptomycin · ATC J01GA01

7 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Streptomycin
Manufacturer
Pharma-Tek
Country
Norway (NO)
ATC code
J01GA01
ATC class
Streptomycin
Defined daily dose
1 g, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_7DC5881E-CBB7-4C6D-B615-645D53E31413
  • no_varenummer
    356816
    10 x 1
  • gtin
    339822070626

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

199 interactions on record for streptomycin.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Streptomycin · interactions on record

199 records

  • 50 severe
  • 126 moderate
  • 2 minor
  • 21 info

Most severe, free to view

  • Magnesium sulfateA06AD04severe
  • MannitolA06AD16severe
  • Polymyxin BA07AA05severe
  • Magnesium sulfateA12CC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Streptomycin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All streptomycin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Spain · Sulfato De Estreptomicina Reig Jofré
  • Poland · Streptomycinum Tzf
  • Portugal · Estreptomicina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/420d32c9-5a2e-496d-92dd-31bff9a9af3e
GET /v1/drugs/420d32c9-5a2e-496d-92dd-31bff9a9af3e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pulver til injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Streptomycin",
  "merkevare_id": "ID_7DC5881E-CBB7-4C6D-B615-645D53E31413",
  "name_form_strength": "Streptomycin x-gen pulv til inj væske, oppl 1 g",
  "prescription_group": "C"
}

See everything about streptomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.